Article Text

PDF
Stenting of left main coronary artery stenosis: A to Z
  1. Debabrata Dash
  1. Department of Cardiology, Fortis Raheja Hospital, Cumballa Hill Hospital, Mumbai, Maharastra, India
  1. Correspondence to Dr Debabrata Dash, Department of Cardiology, Fortis Raheja Hospital, Cumballa Hill Hospital, Raheja Rugnalaya Marg, Mahim West, Mumbai, Maharastra 400016, India; dr_dash2003{at}yahoo.com

Abstract

For several decades, coronary artery bypass grafting (CABG) has been considered as the gold standard treatment of unprotected left main coronary artery (LMCA) disease. The marked improvement in technique and technology makes percutaneous coronary interventions (PCIs) feasible for patients with unprotected LMCA stenosis. The recent introduction of drug-eluting stents (DESs), together with advances in periprocedural and postprocedural adjunctive pharmacotherapies, has improved outcomes of PCIs of these lesions. Recent studies comparing efficacy and safety of PCIs using drug-eluting stents and CABG revealed comparable results in terms of safety and a lower need for repeat revascularisation for CABG. Patient selection for both the techniques directly impacts clinical outcome. Despite improvement in stent technology and operator experience, management can be challenging especially in LMCA bifurcation lesions and, therefore, an integrated approach combining advanced devices, tailored techniques, adjunctive support of physiological evaluation, and adjunctive pharmacological agents should be reinforced to improve clinical outcome.

  • Allied Specialities
  • Interventional Cardiology

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.